COMMUNIQUÉS West-GlobeNewswire
-
Milestone Pharmaceuticals Enrolls First Canadian Study Participant in ReVeRA-301 Phase 3 Pivotal Trial Evaluating Etripamil Nasal Spray for AFib-RVR
24/09/2026 -
Cronos Hosts 2026 Investor Day
24/09/2026 -
Claris Bio Establishes Corporate Headquarters in San Francisco
24/09/2026 -
SL Science Presents Preclinical Data at the 85th Annual Meeting of the Japanese Cancer Association Showing γδ T Cells Target Chemotherapy-Resistant Glioblastoma
24/09/2026 -
Boehringer Ingelheim and WHO Foundation launch global collaboration to close the gap in obesity and metabolic health
24/09/2026 -
IMUNON Makes the Frontline Case for Phase 3 IMNN-001 Study: 14.7-Month OS Signal, Historical IL-12 Safety Barriers Overcome, Enrolling Ahead of Plan
24/09/2026 -
SeaStar Medical Congratulates H. David Humes, M.D., on Receiving the University of Michigan 2026 Distinguished University Innovator of the Year for Development of the SCD Therapy
24/09/2026 -
Free Family Fun Night in Cedar Park: Ally Medical ER Ribbon Cutting
24/09/2026 -
HCW Biologics Announces Pricing of $1.5 Million Private Placement
24/09/2026 -
Applied Biologics Announces Publication of New XWRAP® Translational Research Demonstrating More Favorable Wound-Healing Biology
24/09/2026 -
Autonomix Medical Expands Global Intellectual Property Footprint with European Patent Supporting Precision Neuromodulation Platform
24/09/2026 -
Elliston Health Launches Concierge Medicine for Adults in New York City
24/09/2026 -
Avaí Bio and Austrianova Present Encapsulated Cell Approach to Sustained α-Klotho Delivery at 2026 Klotho Conference
24/09/2026 -
Free Community Cookout in Frisco: Ally Medical ER Ribbon Cutting
24/09/2026 -
Parents in Distress: New Survey Highlights the Impact of Lost Sleep on Busy Parents
24/09/2026 -
Medevise Consulting to Host “Robotics in Ophthalmology” Workshop in New Orleans During AAO 2026
24/09/2026 -
Persevere Therapeutics Announces Treatment of First Patient in its MIROC-1 Phase 2a Ovarian Cancer Clinical Trial
24/09/2026 -
Kessler Foundation and UPnRIDE Launch Research Initiative to Advance What’s Possible for People with Disabilities
24/09/2026 -
SK pharmteco Launches Catalyst Kit to Streamline Catalytic Reaction Development and Continuous Manufacturing Scale-Up
24/09/2026
Pages